about
Conservative laser microsurgery for T1 glottic carcinoma.Fotemustine and dacarbazine plus recombinant interferon alpha 2a in thetreatment of advanced melanoma.Molecular classification of nodal metastasis in primary larynx squamous cell carcinoma.Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents.Leiomyosarcoma of the Oropharynx and Neurogenic Tumors in a Young Patient With Turner's SyndromeClear-cell myoepithelial carcinoma of the salivary glands: a clinicopathologic, immunohistochemical, and ultrastructural study of two cases involving the submandibular gland with review of the literature.Expression analysis of SPARC/osteonectin in oral squamous cell carcinoma patients: from saliva to surgical specimen.Treatment approaches to nasopharyngeal carcinoma: a review.Treatment approaches in elderly patients with head and neck cancer.Detection of predictive markers for therapeutic stratification of salivary glands tumors.HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches.Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literatureUpdate on Head and Neck Cancer: Current Knowledge on Epidemiology, Risk Factors, Molecular Features and Novel Therapies.The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients.Brooke-Spiegler syndrome presenting multiple concurrent cutaneous and parotid gland neoplasms: cytologic findings on fine-needle sample and description of a novel mutation of the CYLD gene.Innovative Surgical Management of the Synovial Chondromatosis of Temporo-Mandibular Joints: Highly Conservative Surgical Technique.Sclerosing polycystic adenosis of the parotid gland: report of one case diagnosed by fine-needle cytology with in situ malignant transformation.Low prevalence of human papillomavirus in squamous-cell carcinoma limited to oral cavity proper.Mobile hospital rooms to fight melanomaPrognostic implications of node metastatic features in OSCC: A retrospective study on 121 neck dissectionsCisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG)Spontaneous infarction of pleomorphic adenoma: report of a case simulating malignancy on fine-needle cytology sampleInduction chemotherapy with docetaxel, cisplatin and capecitabine, followed by combined cetuximab and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck: a phase I-II studyA phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI ) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma
P50
Q33301409-83FB4DFD-7B92-46DE-B80F-4704832A3688Q33500348-C497A1BB-5B81-4533-9407-FBDE579E4543Q34694671-91780746-8110-4626-B273-1930945F2256Q36427867-15875D85-727D-4C7D-8ABB-72EEA8025696Q36690905-0D087CC0-3D22-43C4-86C7-252B8A167343Q37061365-EABBAADD-5548-458C-BFB4-106E29515F72Q37422625-9217DF39-342D-45A0-BF1D-9E84CAEE4577Q37685958-E672F51D-3E4D-4DD3-BC3B-188BB8D0BE95Q38156208-7A721301-0A7D-436B-BCC2-06E4669F65ADQ38219739-2382A170-32D8-446E-89F3-A5C250735E0EQ38223840-739DA375-A40A-4550-A2D3-D8E87595670CQ38228320-CE7D4173-DAC8-4BED-B2DA-0377E870A232Q38476090-3444D19F-3864-48EE-9AC9-00F85053A43BQ39055490-E659FDFF-810B-4DE4-B64E-D011A6278A8CQ40505626-27DCB181-5766-427C-B862-C19F9CF0E7D2Q40917620-971F0F48-910F-4F25-BD20-7C941F69C24AQ52982351-B7EA877B-E236-49DF-945E-36854E2BB988Q53304401-78E50CF9-2A22-4743-8EB4-560561490E28Q54509330-D4EEF273-8426-42A7-9C76-88C66C749325Q57781657-7E786EDF-70E9-44BE-9DDC-40554DE20ACEQ60229483-64084442-D0A4-4380-BA8D-566E6AB14FB0Q74044400-84A32242-49DF-451A-86AC-302F99D31EEEQ84859121-14FF5B53-4645-4AC2-AD96-95EC438384C8Q86179506-267A1870-4F2C-40F0-A44D-2EB8E60DB8E5Q87533045-DC4151BE-20C6-4ECC-B381-1B65C9FCF39D
P50
description
researcher ORCID ID = 0000-0002-0512-274X
@en
wetenschapper
@nl
name
Franco Ionna
@ast
Franco Ionna
@en
Franco Ionna
@es
Franco Ionna
@nl
type
label
Franco Ionna
@ast
Franco Ionna
@en
Franco Ionna
@es
Franco Ionna
@nl
prefLabel
Franco Ionna
@ast
Franco Ionna
@en
Franco Ionna
@es
Franco Ionna
@nl
P1153
P106
P1153
37025536500
6602080359
7004264994
P21
P31
P496
0000-0002-0512-274X